Objective We provide evidence‐based recommendations regarding the treatment of
interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases …

Patients with rheumatoid arthritis (RA) are at increased risk of develo** interstitial lung
disease compared to the general population, a complication that is associated with …

Objective Patient engagement is critical to clinical practice guideline (CPG) development.
This work presents our approach to ascertaining patients' values and preferences to inform …

IIM diseases are complex disorders with significant health impacts, necessitating enhanced
awareness and research. Improved classification and understanding of MSAs are crucial for …

Interstitial lung disease (ILD) is among the most common extra-articular manifestations of
rheumatoid arthritis (RA), with symptomatic disease prevalent in approximately 10% of …

Overdiagnosis occurs when patients are diagnosed with a disease that would otherwise
never have affected the quality or duration of their lives. This often happens unintentionally …

Background We sought consensus among practising respiratory physicians on the
prediction, identification and monitoring of progression in patients with fibrosing interstitial …

Multidisciplinary teams are working to deepen our understanding of SSc-GI disease
pathogenesis, to identify biomarkers for risk stratification and the assessment of disease …

Introduction The clinical characteristics of patients positive for anti-small ubiquitin-like
modifier 1-activating enzyme subunit 1 (SAE1) antibodies and diagnosed with idiopathic …

Abstract Purpose of Review The purpose of this review is to outline considerations for
treating older adults with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) as …